Surgeons Plan for First Penis Transplants in the U.S.
New Research Analyzes Nutraceutical Ingredients
Johns Hopkins University School of Medicine has approved 60 penis transplants in a new clinical trial, the first in the United States.
The investigational program is expected to start within a few months. If successful, the university will decide whether to offer penis transplants as standard treatment.
The first patients will be soldiers who have sustained genital injuries in combat. Full recovery of urinary and sexual function could take six to twelve months, but there are no guarantees.
Patients will undergo psychiatric counseling as well. After their transplants, they will need to take anti-rejection medications for the rest of their lives.
The new penises will come from deceased donors with the permission of family members.
Only two other penis transplants have been performed worldwide. The first occurred in China in 2006. While the physical aspects of the surgery went well, the new penis was soon removed, as the patient experienced psychological issues.
The second transplant took place in South Africa in late 2014. That surgery was a success and the patient has since impregnated his girlfriend.
Please click here for more details.
We're pleased to announce that a new research summary has been posted to the ISSM website.
"A Urologist’s Guide to Ingredients Found in Top-Selling Nutraceuticals for Men’s Sexual Health" by Tao Cui MD, et al. was first published online in November in The Journal of Sexual Medicine.
The article discusses some of the most common active ingredients in products marketed for male sexual enhancement, including red ginseng, B vitamins, yohimbine, and more.
The complete summary is available here.